171 related articles for article (PubMed ID: 34651207)
1. Utility of Immunohistochemistry and Immunofluorescence in Determining the Pathogenic Variants of Chronic Granulomatous Disease.
Sekar A; Gupta K; Rawat A; Jindal A; Pandiarajan V; Suri D; Gupta A; Kaur G; Kumar I; Gummadi A; Sil A; Singh S
J Clin Immunol; 2022 Jan; 42(1):85-93. PubMed ID: 34651207
[TBL] [Abstract][Full Text] [Related]
2. Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.
Kulkarni M; Hule G; de Boer M; van Leeuwen K; Kambli P; Aluri J; Gupta M; Dalvi A; Mhatre S; Taur P; Desai M; Madkaikar M
J Clin Immunol; 2018 Nov; 38(8):898-916. PubMed ID: 30470980
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
[TBL] [Abstract][Full Text] [Related]
4. A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.
Ben-Farhat K; Ben-Mustapha I; Ben-Ali M; Rouault K; Hamami S; Mekki N; Ben-Chehida A; Larguèche B; Fitouri Z; Abdelmoula S; Khemiri M; Guediche MN; Boukthir S; Barsaoui S; Chemli J; Barbouche MR
J Clin Immunol; 2016 Aug; 36(6):547-54. PubMed ID: 27220316
[TBL] [Abstract][Full Text] [Related]
5. Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease.
Aygun D; Koker MY; Nepesov S; Koker N; van Leeuwen K; de Boer M; Kıykım A; Ozsoy S; Cokugras H; Kuijpers T; Roos D; Camcıoglu Y
Int Arch Allergy Immunol; 2020; 181(7):540-550. PubMed ID: 32512560
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease.
Wada T; Muraoka M; Toma T; Imai T; Shigemura T; Agematsu K; Haraguchi K; Moriuchi H; Oh-Ishi T; Kitoh T; Ohara O; Morio T; Yachie A
J Clin Immunol; 2013 May; 33(4):857-64. PubMed ID: 23306776
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular significance of flow cytometric analysis for reactive oxygen species production and residual p67
Miyazawa H; Muraoka M; Matsuda Y; Toma T; Morio T; Shigemura T; Haraguchi K; Matsubayashi T; Kawai T; Shirai Y; Wada T
Scand J Immunol; 2024 Jul; 100(1):e13372. PubMed ID: 38654426
[TBL] [Abstract][Full Text] [Related]
8. Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience.
El Hawary R; Meshaal S; Deswarte C; Galal N; Abdelkawy M; Alkady R; Elaziz DA; Freiberger T; Ravcukova B; Litzman J; Bustamante J; Boutros J; Gaafar T; Elmarsafy A
J Clin Immunol; 2016 Aug; 36(6):610-8. PubMed ID: 27222152
[TBL] [Abstract][Full Text] [Related]
9. Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.
Bakri FG; Mollin M; Beaumel S; Vigne B; Roux-Buisson N; Al-Wahadneh AM; Alzyoud RM; Hayajneh WA; Daoud AK; Shukair MEA; Karadshe MF; Sarhan MM; Al-Ramahi JAW; Fauré J; Rendu J; Stasia MJ
Front Immunol; 2021; 12():639226. PubMed ID: 33746979
[TBL] [Abstract][Full Text] [Related]
10. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical Exemplar.
Donko A; Kuhns DB; Cousin MA; Smith MJ; Sacco KA; Klee EW; Joshi AY; Gavrilova RH; Holland SM; Leto TL; Abraham RS
J Clin Immunol; 2022 Jul; 42(5):986-999. PubMed ID: 35344128
[TBL] [Abstract][Full Text] [Related]
12. [Bacillus Calmette-Guérin infection and chronic granulomatous disease due to new pathogenic variants in the NCF2 gene in the Mayan ethnic group. Report of two cases.].
Peñafiel-Vicuña AK; Coyata-Guzmán R; González Reynoso A; Palma-Chan AG; Baeza-Bastarrachea R; García-Ruelas SA; Costta-Michuy Á; Razo-Requena C; León-Lara X; Espinosa-Padilla S; Espinosa-Rosales F; Bustamante J; Blancas-Galicia L
Rev Alerg Mex; 2023 Apr; 69(4):220-227. PubMed ID: 37218049
[TBL] [Abstract][Full Text] [Related]
13. De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease.
Yu L; Li W; Lv G; Sun G; Yang L; Chen J; Zhou L; Ding Y; Zhang Z; Tang X; An Y; Zhao X
J Clin Immunol; 2023 Jan; 43(1):88-100. PubMed ID: 35997928
[TBL] [Abstract][Full Text] [Related]
14. Intersecting Stories of the Phagocyte NADPH Oxidase and Chronic Granulomatous Disease.
Nauseef WM; Clark RA
Methods Mol Biol; 2019; 1982():3-16. PubMed ID: 31172463
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
[TBL] [Abstract][Full Text] [Related]
16. NAPDH Oxidase-Specific Flow Cytometry Allows for Rapid Genetic Triage and Classification of Novel Variants in Chronic Granulomatous Disease.
Sacco KA; Smith MJ; Bahna SL; Buchbinder D; Burkhardt J; Cooper MA; Hartog NL; Kobrynski L; Patel KP; Abraham RS
J Clin Immunol; 2020 Jan; 40(1):191-202. PubMed ID: 31813112
[TBL] [Abstract][Full Text] [Related]
17. The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.
Sun J; Wen M; Wang Y; Liu D; Ying W; Wang X
BMC Med Genet; 2017 Nov; 18(1):127. PubMed ID: 29132304
[TBL] [Abstract][Full Text] [Related]
18. [Laboratory diagnosis of chronic granulomatous disease].
Zhou QH; Liu DR; Wang Y; Ying WJ; Yu YH; Wang JY; Hui XY; Sun JQ; Hou J; Wang WJ; Wang XC
Zhonghua Er Ke Za Zhi; 2016 May; 54(5):337-43. PubMed ID: 27143074
[TBL] [Abstract][Full Text] [Related]
19. Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.
Mollin M; Beaumel S; Vigne B; Brault J; Roux-Buisson N; Rendu J; Barlogis V; Catho G; Dumeril C; Fouyssac F; Monnier D; Gandemer V; Revest M; Brion JP; Bost-Bru C; Jeziorski E; Eitenschenck L; Jarrasse C; Drillon Haus S; Houachée-Chardin M; Hancart M; Michel G; Bertrand Y; Plantaz D; Kelecic J; Traberg R; Kainulainen L; Fauré J; Fieschi F; Stasia MJ
Clin Exp Immunol; 2021 Feb; 203(2):247-266. PubMed ID: 32954498
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of chronic granulomatous disease.
Roos D; de Boer M
Clin Exp Immunol; 2014 Feb; 175(2):139-49. PubMed ID: 24016250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
